Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Armata Pharmaceuticals, Inc. (TGEN) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Armata Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 921114.
Total stock buying since 2015: $94,828,052.
Total stock sales since 2015: $84,375.
Total stock option exercises since 2015: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 9,000,000 | $45,000,000 | 0 | $0 | 0 | $0 |
| 2021 | 7,365,969 | $24,000,004 | 0 | $0 | 0 | $0 |
| 2020 | 7,717,661 | $22,149,687 | 0 | $0 | 0 | $0 |
| 2018 | 363,640 | $400,004 | 0 | $0 | 0 | $0 |
| 2017 | 221,544 | $0 | 0 | $0 | 0 | $0 |
| 2016 | 233,021 | $345,328 | 177,020 | $84,375 | 0 | $0 |
| 2015 | 14,023,047 | $2,933,029 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-03 | 5,385,208 | $26,926,040 | 0 | $0 | 0 | $0 |
| 2022-02 | 3,614,792 | $18,073,960 | 0 | $0 | 0 | $0 |
| 2021-10 | 1,212,122 | $4,000,002 | 0 | $0 | 0 | $0 |
| 2021-03 | 4,285,935 | $13,929,288 | 0 | $0 | 0 | $0 |
| 2021-01 | 1,867,912 | $6,070,714 | 0 | $0 | 0 | $0 |
| 2020-03 | 7,717,661 | $22,149,687 | 0 | $0 | 0 | $0 |
| 2018-03 | 363,640 | $400,004 | 0 | $0 | 0 | $0 |
| 2017-09 | 210,030 | $0 | 0 | $0 | 0 | $0 |
| 2017-06 | 11,514 | $0 | 0 | $0 | 0 | $0 |
| 2016-12 | 0 | $0 | 177,020 | $84,375 | 0 | $0 |
| 2016-11 | 46,666 | $345,328 | 0 | $0 | 0 | $0 |
| 2016-06 | 15,057 | $0 | 0 | $0 | 0 | $0 |
| 2016-04 | 171,298 | $0 | 0 | $0 | 0 | $0 |
| 2015-10 | 15,200 | $68,277 | 0 | $0 | 0 | $0 |
| 2015-03 | 14,007,847 | $2,864,752 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-31 | Innoviva Strategic Opportunities Llc | Buy | 5,385,208 | 5.00 | 26,926,040 |
| 2022-02-09 | Innoviva Strategic Opportunities Llc | Buy | 3,614,792 | 5.00 | 18,073,960 |
| 2021-10-29 | Innoviva Strategic Opportunities Llc | Buy | 1,212,122 | 3.30 | 4,000,002 |
| 2021-03-17 | Innoviva Strategic Opportunities Llc | Buy | 4,285,935 | 3.25 | 13,929,288 |
| 2021-01-26 | Innoviva Strategic Opportunities Llc (Director) | Buy | 1,867,912 | 3.25 | 6,070,714 |
| 2020-03-27 | Innoviva, Inc. | Buy | 7,717,661 | 2.87 | 22,149,687 |
| 2018-03-22 | Perry Michael S (Director) | Buy | 181,820 | 1.10 | 200,002 |
| 2018-03-22 | Cook Jeremy Curnock (Director) | Buy | 181,820 | 1.10 | 200,002 |
| 2017-09-19 | Perry Michael S (Director) | Buy | 105,015 | .00 | 0 |
| 2017-09-19 | Cook Jeremy Curnock (Director) | Buy | 105,015 | .00 | 0 |
| 2017-06-29 | Perry Michael S (Director) | Buy | 5,757 | .00 | 0 |
| 2017-06-29 | Cook Jeremy Curnock (Director) | Buy | 5,757 | .00 | 0 |
| 2016-12-29 | Intrexon Corp | Sale | 42,000 | .45 | 18,900 |
| 2016-12-28 | Intrexon Corp | Sale | 84,620 | .47 | 39,771 |
| 2016-12-27 | Intrexon Corp | Sale | 50,400 | .51 | 25,704 |
| 2016-11-22 | Cook Jeremy Curnock (Director) | Buy | 46,666 | 7.40 | 345,328 |
| 2016-06-21 | Cook Jeremy Curnock (Director) | Buy | 15,057 | .00 | 0 |
| 2016-04-08 | Cook Jeremy Curnock (Director) | Buy | 171,298 | .00 | 0 |
| 2015-10-06 | Drapeau Louis (Director) | Buy | 10,000 | 4.39 | 43,900 |
| 2015-10-05 | Johnson Wendy S. (Interim Chief Operating Office) | Buy | 1,000 | 4.43 | 4,427 |
| 2015-10-05 | Salka Michael Scott (Chief Executive Officer) | Buy | 4,200 | 4.75 | 19,950 |
| 2015-03-16 | Intrexon Corp | Buy | 13,939,392 | .17 | 2,299,999 |
| 2015-03-16 | Cook Jeremy Curnock (Director) | Buy | 68,455 | 8.25 | 564,753 |
Insider trading activities including stock purchases, stock sales, and option exercises of TGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Armata Pharmaceuticals, Inc. (symbol TGEN, CIK number 921114) see the Securities and Exchange Commission (SEC) website.